BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35533029)

  • 1. Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma.
    Misitzis A; Stratigos A; Mastorakos G; Weinstock M
    J Drugs Dermatol; 2022 May; 21(5):502-505. PubMed ID: 35533029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of metformin use with keratinocyte carcinoma development in high-risk patients.
    Misitzis A; Stratigos AJ; Beatson M; Mastorakos G; Dellavalle RP; Weinstock MA;
    Dermatol Ther; 2020 Nov; 33(6):e14402. PubMed ID: 33047438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
    Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
    JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
    Wu S; Cho E; Li WQ; Qureshi AA
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
    Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
    Baibergenova AT; Weinstock MA;
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
    Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study.
    Mahamat-Saleh Y; Savoye I; Cervenka I; Al-Rahmoun M; Cadeau C; Boutron-Ruault MC; Kvaskoff M
    Eur J Nutr; 2022 Aug; 61(5):2825-2836. PubMed ID: 35292856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
    Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
    J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland.
    Adalsteinsson JA; Muzumdar S; Waldman R; Wu R; Ratner D; Feng H; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
    J Am Acad Dermatol; 2021 Jul; 85(1):56-61. PubMed ID: 33610593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.
    Dore DD; Lapane KL; Trivedi AN; Mor V; Weinstock MA
    Ann Intern Med; 2009 Jan; 150(1):9-18. PubMed ID: 19124815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
    Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
    J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.